Recently, there is increasing evidence that CDR1as is overexpressed in many tumor types, such as colorectal cancer (Tang et al., 2017), cholangiocarcinoma (Jiang et al., 2018) and osteosarcoma (Xu et al., 2018), and plays a vital role in the development of cancer. Here, LINC00632 is linked to neoplasm.